Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Ductal, Lobular, and Medullary

Explore clinical trials studying Neoplasms, Ductal, Lobular, and Medullary. Study availability and eligibility vary by location and protocol.

480 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Ductal, Lobular, and Medullary trial results

Recruiting

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

NCT05919108

Conditions
Adenocarcinoma, Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, +13 more
Locations
  • Emory University/ Winship Cancer Institute Atlanta, Georgia, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
  • University of Texas, Southwestern Dallas, Texas, United States
View Trial Details
Recruiting

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)

NCT04797299

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BC Cancer - Abbotsford Centre Abbotsford British Columbia, British Columbia, Canada
  • BC Cancer - Centre for the North (Prince George) Prince George, British Columbia, Canada
View all 25 locations
View Trial Details
Recruiting

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

NCT07214532

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Marin Cancer Care Greenbrae, California, United States
View all 48 locations
View Trial Details
Recruiting

Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation

NCT05288205

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +31 more
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • Pecking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital Chinese Academy Of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Tiantan Hospital, Captal Medical University Beijing, Beijing Municipality, China
View all 27 locations
View Trial Details
Recruiting

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

NCT05859074

Conditions
Adenocarcinoma, Adenocarcinoma, Sebaceous, Adnexal Carcinoma, +58 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details

Related conditions